Effects of Slow-stroke Back Massage on Chemotherapy-induced Nausea and Vomiting in the Pediatrics with Acute Leukemia: a Challenge of Controlling Symptoms

被引:0
|
作者
Miladinia, Mojtaba [1 ]
Baraz, Shahram [1 ]
Nouri, Elham Mousavi [1 ]
Baeis, Mehdi Gholamzadeh [2 ]
机构
[1] Ahvaz Jundishapur Univ Med Sci, Sch Nursing & Midwifery, Chron Dis Care Res Ctr, Golestan Sq, Ahvaz, Iran
[2] Islamic Azad Univ, Qom Branch, Young Researchers & Elites Club, Qom, Iran
来源
INTERNATIONAL JOURNAL OF PEDIATRICS-MASHHAD | 2015年 / 3卷 / 06期
关键词
Complementary medicine; Leukemia; Massage; Nausea; Pediatric; Vomiting;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Introduction Nausea and vomiting are the most common side effects of chemotherapy in the pediatrics with cancer which affect their quality of life. Use of some methods of complementary medicine in leukemia patients is problematic. Because, leukemia patients are at risk of infection and bleeding, therefore the use of acupressure, acupuncture, and deep massage can be risky in these patients. Slow-stroke back massage is applied on the surface of body, so does not have complications. No study has addressed the effect of massage therapy on chemotherapy-induced nausea and vomiting in pediatrics with acute leukemia in the world. Material and methods This study was a two-group randomized controlled trial (RCT), double blind and repeated measures design. In this RCT, 45 school age children with acute leukemia were placed in the massage and control groups. Before start of the study, at the day of chemotherapy administration (day 1th), only nausea and vomiting were measured. Then during 6 days next (day 2 through 7), the intervention group received 5-minutes Super Smash Bros. Melee (SSBM), immediately before start of each session of chemotherapy. Nausea was measured during chemotherapy, 0.5 h and 3 h after each session of chemotherapy in the two groups. Also vomiting was recorded during 24 h after each session of chemotherapy. Repeated measures ANOVA, Chi-square, and t-test were used for analysis. Results Most of pediatrics were male (58.13%), and suffered from Acute myeloid leukemia (AML) (81.7%). The repeated measure analysis showed that in the intervention group, the SSBM reduced progressive mean of nausea severity and frequency of vomit over time. While, this side effects have slightly increased over time in the control group. Conclusion The results of this study are suggesting that SSBM, as a non-pharmacologic, easy and safe method, is effective in controlling Chemotherapy-induced nausea and vomiting (CINV) in the pediatrics with acute leukemia.
引用
收藏
页码:1145 / 1152
页数:8
相关论文
共 45 条
  • [41] Prospective evaluation of clinical symptoms of chemotherapy-induced oral mucositis in adult patients with acute leukemia: A preliminary study
    Lee, Yeon-Hee
    Hong, Junshik
    Kim, Inho
    Choi, Youngnim
    Park, Hee-Kyung
    CLINICAL AND EXPERIMENTAL DENTAL RESEARCH, 2020, 6 (01): : 90 - 99
  • [42] A Randomized, Double-blind, Parallel, Comparative Study to Evaluate the Efficacy and Safety of Ramosetron plus Dexamethasone Injection for the Prevention of Acute Chemotherapy-induced Nausea and Vomiting
    Ho, Ching-Liang
    Su, Wu-Chou
    Hsieh, Ruey-Kuen
    Lin, Zhong-Zhe
    Chao, Tsu-Yi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (04) : 294 - 301
  • [43] The oral NK1 antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting:: Pooled data from 2 randomised, double-blind, placebo controlled trials
    Warr, DG
    Grunberg, SM
    Gralla, RJ
    Hesketh, PJ
    Roila, F
    de Wit, R
    Carides, AD
    Taylor, A
    Evans, JK
    Horgan, KJ
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (09) : 1278 - 1285
  • [44] A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab
    Affronti, Mary Lou
    Woodring, Sarah
    Peters, Katherine B.
    Herndon, James E., II
    McSherry, Frances
    Healy, Patrick N.
    Desjardins, A. Nnick
    Vredenburgh, James J.
    Friedman, Henry S.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 33 - 40
  • [45] Randomized Controlled Study Comparing Two Doses of Intravenous Granisetron (1 and 3 mg) for Acute Chemotherapy-induced Nausea and Vomiting in Cancer Patients: A Non-inferiority Trial
    Yonemura, Masahito
    Katsumata, Noriyuki
    Hashimoto, Hironobu
    Satake, Shoko
    Kaneko, Masayuki
    Kobayashi, Yuka
    Takashima, Atsuo
    Kato, Yasuhisa
    Takeuchi, Masahiro
    Fujiwara, Yasuhiro
    Yamamoto, Hiroshi
    Hojo, Taisuke
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (07) : 443 - 448